Lb Pharmaceuticals Inc (LBRX)

Jan 06, 2026

LB Pharmaceuticals Appoints Ellen Rose and Lindsay Beaupre as Senior Vice Presidents - citybiz

Jan 06, 2026

Jan 06, 2026

LB Pharmaceuticals appoints two executives to leadership team By Investing.com - Investing.com Canada

Jan 06, 2026

Jan 06, 2026

LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture - The Manila Times

Jan 06, 2026

Jan 04, 2026

Schizophrenia drug developer LB Pharma jumps in trading debut - MSN

Jan 04, 2026

Jan 02, 2026

LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 7.7%Should You Sell? - MarketBeat

Jan 02, 2026

Dec 31, 2025

LB Pharmaceuticals (NASDAQ:LBRX) Trading Up 3.8%Here's Why - MarketBeat

Dec 31, 2025

Dec 23, 2025

Top financings 2025 - BioWorld MedTech

Dec 23, 2025

Dec 23, 2025

LB Pharmaceuticals Inc (NASDAQ:LBRX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 23, 2025

Dec 21, 2025

LB Pharmaceuticals Inc(NasdaqGM: LBRX) added to S&P TMI Index - marketscreener.com

Dec 21, 2025

Dec 19, 2025

Aktis Oncology files for US IPO as biotech listings rebound - 1470 & 100.3 WMBD

Dec 19, 2025

Dec 19, 2025

Pai Panandiker Kaya Kamlesh Net Worth (2025) - GuruFocus

Dec 19, 2025

Dec 18, 2025

LB Pharmaceuticals Inc(NasdaqGM: LBRX) added to Russell 3000 Index - marketscreener.com

Dec 18, 2025

Dec 18, 2025

LB Pharmaceuticals Inc(NasdaqGM: LBRX) added to Russell 2000 Index - marketscreener.com

Dec 18, 2025

Dec 15, 2025

LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Up 5.6%What's Next? - MarketBeat

Dec 15, 2025

Dec 11, 2025

[Form 4] LB PHARMACEUTICALS INC Insider Trading Activity - Stock Titan

Dec 11, 2025

Dec 11, 2025

LB Pharmaceuticals added to Russell 2000 and 3000 Indexes - MSN

Dec 11, 2025

Dec 11, 2025

LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat

Dec 11, 2025

Dec 11, 2025

Lexicon publishes preclinical data validating ACSL5 as obesity target By Investing.com - Investing.com Nigeria

Dec 11, 2025

Dec 10, 2025

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Dec 10, 2025

Dec 10, 2025

LB Pharmaceuticals (Nasdaq: LBRX) issues inducement equity grant to incoming CCO - Stock Titan

Dec 10, 2025

Dec 10, 2025

LB Pharmaceuticals (LBRX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 10, 2025

Dec 10, 2025

Lexicon publishes preclinical data validating ACSL5 as obesity target - Investing.com

Dec 10, 2025

Dec 10, 2025

LB Pharmaceuticals Added to the Russell 2000 and Russell 3000 Indices - marketscreener.com

Dec 10, 2025

Dec 09, 2025

LB Pharmaceuticals (NASDAQ:LBRX) Trading Down 4.8%Here's Why - MarketBeat

Dec 09, 2025

Dec 09, 2025

LB Pharmaceuticals Added to Russell 2000, 3000 Indices - marketscreener.com

Dec 09, 2025

Dec 09, 2025

LB Pharmaceuticals to join Russell 2000 and Russell 3000 indices - Investing.com

Dec 09, 2025

Dec 09, 2025

LB Pharmaceuticals to join Russell 2000 and Russell 3000 indices By Investing.com - Investing.com Canada

Dec 09, 2025

Dec 09, 2025

LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices - marketscreener.com

Dec 09, 2025

Dec 08, 2025

LB Pharmaceuticals (NASDAQ:LBRX) Trading Up 6.2%Still a Buy? - MarketBeat

Dec 08, 2025

Dec 06, 2025

LB Pharmaceuticals (NASDAQ:LBRX) Hits New 52-Week HighHere's What Happened - MarketBeat

Dec 06, 2025

Dec 03, 2025

LBRX: $300M IPO funds phase III schizophrenia and phase II bipolar depression trials, with 2027 data expected - TradingView

Dec 03, 2025

Dec 03, 2025

LB Pharmaceuticals Inc (LBRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Dec 03, 2025

Dec 01, 2025

LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives $30.50 Average PT from Brokerages - Defense World

Dec 01, 2025

Nov 29, 2025

LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Nov 29, 2025

Nov 24, 2025

LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference - The Manila Times

Nov 24, 2025

Nov 19, 2025

Neuropsychiatric drug developer LB Pharma files for U.S. IPO - MSN

Nov 19, 2025

Nov 17, 2025

LB Pharmaceuticals Inc: Target Price Consensus and Analysts Recommendations | LBRX | US50180M1080 - MarketScreener

Nov 17, 2025

Nov 17, 2025

LB Pharmaceuticals Inc: Revenue and Earnings Analysts Forecasts Revisions | LBRX | US50180M1080 - MarketScreener

Nov 17, 2025

Nov 17, 2025

LB Pharmaceuticals Inc: Dividend historical data and projections - MarketScreener

Nov 17, 2025

Nov 17, 2025

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday - Benzinga

Nov 17, 2025

Nov 13, 2025

LB Pharmaceuticals Appoints New Chief Commercial Officer - MSN

Nov 13, 2025

Nov 13, 2025

LB Pharmaceuticals amends lease to expand New York office space By Investing.com - Investing.com Australia

Nov 13, 2025

Nov 13, 2025

LB Pharmaceuticals Expands Lease at One Penn Plaza - TipRanks

Nov 13, 2025

Nov 13, 2025

LB Pharmaceuticals amends lease to expand New York office space - Investing.com India

Nov 13, 2025

Nov 13, 2025

[8-K] LB PHARMACEUTICALS INC Reports Material Event | LBRX SEC FilingForm 8-K - Stock Titan

Nov 13, 2025

Nov 12, 2025

LB Pharmaceuticals appoints Kaya Pai Panandiker as chief commercial officer - Investing.com Nigeria

Nov 12, 2025

Nov 12, 2025

LB Pharmaceuticals names Kaya Pai Panandiker as CCO - The Pharma Letter

Nov 12, 2025